v3.26.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Significant Segment Expenses

Significant segment expenses are set forth in the following table (in thousands):

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

Revenue

 

$

15,230

 

 

$

32,110

 

Less:

 

 

 

 

 

 

Cost of revenue

 

 

5,659

 

 

 

10,607

 

Sales and marketing

 

 

10,804

 

 

 

25,933

 

Clinical trials and medical affairs

 

 

3,020

 

 

 

9,455

 

Product development

 

 

1,848

 

 

 

3,190

 

Digital

 

 

969

 

 

 

2,379

 

Quality and regulatory

 

 

1,733

 

 

 

2,345

 

General and administrative

 

 

21,353

 

 

 

28,399

 

Other segment items (1)

 

 

(1,401

)

 

 

(43,000

)

Net loss

 

$

(28,755

)

 

$

(7,198

)

(1) Other segment items included in Net loss primarily include changes in fair value of warrant liabilities, changes in fair value of debt, changes in fair value of the Revenue Interest Financing, loss on extinguishment of debt, interest expense, and other income.
Schedule of Long-lived Assets by Geography

Long-lived assets, consisting of property and equipment, net and ROU assets by geography were as follows (in thousands):

 

 

December 31,

 

 

2025

 

 

2024

 

United States

 

$

2,317

 

 

$

3,929

 

France

 

 

 

 

 

619

 

Long-lived assets

 

$

2,317

 

 

$

4,548